Table 2

Clinico-pathological and radiological characteristics of patients with TTF-1 positive primary breast cancers
Patient number Sample type TTF-1 expression (staining index) Tumor diameter (mm) Grade Tumor-positive lymph-nodes ER PR Her2 CK 5/6 and/or P-cadherin Ki 67 (%) Mode of presentation Mammo-graphy findings Distance from skin (mm) Follow-up time after tumor diagnosis (months) Status
1 SS Weak (2) 27 3 1/12 - - + + 50,5 Screening Stellate opacity 47 29 DEAD
2 SS Strong (9) 15 1 0/3 + + - - 25,4 Interval Irregular microlobulated density 36 61 AW
3 SS Weak (3) 22 3 1/21 - - - + 41,2 Interval Diffuse density 30 38 AW
4 SS Weak (2) 9 2 1/11 + + - - 14,5 Screening Irregular partially rounded mass 8 60 AW
5 SS Weak (2) 21 3 1/14 - - - + 41,2 Screening Irregular density 18 49 AW
6 SS Strong (9) 17 2 1/8 + + - - 22,9 Screening Irregular density 33 54 AW
7 CNB Strong (6) 70 3 0/1 + - - + 55,4 Interval Lobulated mass density 16 60 AW

SS, Surgical specimen; CNB, Core needle biopsy; ER, Estrogen receptor; PR, Progesterone receptor; DEAD, Dead of disease; AW, Alive and well.

Klingen et al.

Klingen et al. Diagnostic Pathology 2013 8:80   doi:10.1186/1746-1596-8-80

Open Data